To clarify the impact of HOXD11 expression level on the prognosis of gliomas of different molecular subtypes, we divided the samples into three groups (IDH mutation with 1p19q codeletion, IDH mutation without 1p19q codeletion and IDH wild type) for survival analysis. Here, HOXD11 is linked to central nervous system cancer.